Pentoxifylline to boost liver regrowth after right‑lobe donor hepatectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled interventional trial at a single tertiary liver center comparing injection pentoxifylline with a control (Plasmalyte) in live donors undergoing right‑lobe hepatectomy. The drug is given perioperatively and donors are followed with clinical exams, blood tests of liver function, and imaging to track liver volume and recovery. The main aim is to determine whether pentoxifylline improves markers of liver regeneration and reduces posthepatectomy liver dysfunction. Eligible participants are consenting live donors without hypersensitivity to pentoxifylline.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All live donors undergoing Right Donor Hepatectomy after ethical board clearance in the Department of HPB Surgery and Liver Transplantation

Exclusion Criteria:

* Negative consent Hypersensitivity to Pentoxifylline

Where it's running

• Institute of Liver and Biliary Sciences
  New Delhi, India Recruiting

Study contacts

• Study coordinator: Parneet Dr
• Email: parneet.sunam@gmail.com
• Phone: +917888524169

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How ALPPS surgery affects liver regrowth after major liver cancer operations

  This project will follow adults with liver cancer who undergo ALPPS surgery to see if the quickly regrown liver tissue works well and how that relates to cancer coming back.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07142213

• Using breath carbon monoxide to predict liver recovery after partial hepatectomy

  This will test whether measuring carbon monoxide in breath can help predict how well adults recover liver function after part of their liver is removed.

  Recruiting Englewood Hospital and Medical Center · Englewood, New Jersey · NCT06681818

• Using high-dose insulin therapy to enhance liver function before surgery

  This study is testing if high-dose insulin therapy can help improve liver function in patients who are about to have major liver surgery.

  Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT06126419

• Digital planning for implants in the upper back jaw after a sinus lift

  This project will test whether digital planning and the position of implants after a sinus lift affect bone levels, gum health, crown shape, and patient satisfaction in adults with implants in the upper back jaw.

  Recruiting Saint-Joseph University · Beirut, Beirut · NCT07526337

• Guided bone regeneration using xenograft mixed with donor (allogenic) bone versus xenograft mixed with your own (autogenous) bone to rebuild upper jaw ridges

  This will test whether mixing xenograft with donor bone works as well as mixing xenograft with a patient's own bone to rebuild narrow upper jaw ridges before implant placement.

  Recruiting Cairo University · Cairo · NCT07367464

• Rebuilding bone in the lower back jaw with resorbable or non‑resorbable membranes

  This trial tests whether a resorbable pericardium membrane or a non‑resorbable PTFE membrane better helps rebuild horizontal bone in the lower back jaw for people who need bone grafting before dental implants.

  Recruiting Beirut Arab University · Beirut · NCT07254494

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.